Spruce Biosciences Raises $88 Million in Series B Financing, co-led …

San Francisco, California — February 19, 2020 – Spruce Biosciences today announced it has raised $88 million in Series B financing co-led by Omega Funds and Abingworth and …

CouponFollow Extension

$88
OFF

Spruce Biosciences Raises $88 Million In Series B Financing, Co-led …

6 days from now

San Francisco, California — February 19, 2020 – Spruce Biosciences today announced it has raised $88 million in Series B financing co-led by Omega Funds and Abingworth and …

sprucebio.com

$88
OFF

Spruce Biosciences – Funding, Valuation, Investors, News

6 days from now

Spruce Biosciences Raises $88M in Series B Financing Spruce Biosciences, a San Francisco, CA-based clinical stage biopharmaceutical company, raised $88m in Series B financing. The …

parsers.vc

$88
OFF

Omega Funds Co-leads Spruce Biosciences' $88M Series B

6 days from now

Feb 19, 2020 · Gunderson Dettmer client Omega Funds co-led the $88 million Series B financing of Spruce Biosciences, a bio-pharmaceutical company developing novel therapies for rare …

gunder.com

$88
OFF

Trusted Insight | Spruce Biosciences Raises $88M In Series B …

6 days from now

SAN FRANCISCO, February 20, 2020-- Spruce Biosciences today announced it has raised $88 million in Series B financing co-led by Omega Funds and Abingworth and supported by …

thetrustedinsight.com

$88
OFF

Spruce Biosciences Raises $88 Million In Series B Financing

6 days from now

Feb 20, 2020 · Proceeds to advance development of Tildacerfont in Congenital Adrenal Hyperplasia and other indications

biospace.com

$88
OFF

Wilson Sonsini Advises Spruce Biosciences On IP Matters Related …

6 days from now

On February 19, 2020, Spruce Biosciences, a clinical stage biopharmaceutical company developing therapeutics for rare endocrine diseases, announced it has raised $88 million in …

wsgr.com

$88
OFF

Series B - Spruce Biosciences - 2020-02-20 - Crunchbase

6 days from now

Feb 20, 2020 · FinSMEs — Spruce Biosciences Raises $88M in Series B Financing . News • Feb 20, 2020. Business Wire — Spruce Biosciences Raises $88 Million in Series B Financing, co …

crunchbase.com

$88
OFF

Spruce Biosciences Closes On $88 Million Series B Round

6 days from now

Feb 20, 2020 · Spruce intends to use the funds raised to evaluate tildacerfont to reduce glucocorticoid steroid usage in adults with CAH, and to complete proof-of-concept trials in …

biospace.com

$88
OFF

Spruce Biosciences Raises $88 Million In Series B Financing, Co …

6 days from now

Spruce Biosciences Raises $88 Million in Series B Financing, co-led by Omega Funds and Abingworth February 19, 2020 ... Spruce Biosciences is a clinical-stage biotechnology …

sprucebio.com

$88
OFF

HealthCap Partners Portfolio Investments, HealthCap Partners …

6 days from now

Feb 21, 2020 · Spruce Biosciences Raises $88 Million in Series B Financing, co-led by Omega Funds and Abingworth. Feb 21, 2020 - Proceeds to advance development of Tildacerfont in …

cbinsights.com

$88
OFF

Spruce Biosciences Raises $88 Million In Series B Financing, Co-led …

6 days from now

Feb 20, 2020 · SAN FRANCISCO--(BUSINESS WIRE)--Spruce Biosciences today announced it has raised $88 million in Series B financing co-led by Omega Funds and Abingworth and …

businesswire.com

$88
OFF

Spruce Biosciences Raises $88 Million In Series B Financing, Co-led …

6 days from now

San Francisco, California — February 19, 2020 – Spruce Biosciences today announced it has raised $88 million in Series B financing co-led by Omega Funds and Abingworth and …

healthcap.eu